Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2016 Publisher: Kora Corporation Ltd t/a Kora Healthcare, Swords Business Park, Swords, Co. Dublin, Ireland
Magnaspartate 243 mg powder for oral solution.
| Pharmaceutical Form |
|---|
|
Powder for oral solution. White powder with a peach/apricot-like flavour. |
Each 6.5 g sachet of powder contains magnesium aspartate dihydrate equivalent to 243 mg (10 mmol) of magnesium.
Excipient(s) with known effect: Each sachet contains 2.706g sucrose.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Magnesium aspartate |
Magnesium is a cofactor in >300 enzymatic reactions. It acts as an essential co-factor for all ATP-binding enzymes. Magnesium plays an important role in cellular electrolyte homeostasis and in the neuromuscular membrane stabilization. |
| List of Excipients |
|---|
|
Sucrose |
Sachets.
Laminated foil (Paper/Aluminium/Polyethylene).
10 sachets.
Kora Corporation Ltd t/a Kora Healthcare, Swords Business Park, Swords, Co. Dublin, Ireland
PL 39972/0002
07/11/2014
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
